Non-steroidal anti-inflammatory drugs and antihypertensive drug therapy

Journal of Hypertension

Volumn 20, Issue 5, 2002, Pages 849-850

  Beilin, Lawrence J ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; ANTIHYPERTENSIVE AGENT; CYCLOOXYGENASE 2 INHIBITOR; ENALAPRIL; INDOMETACIN; LISINOPRIL; NITRENDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; VALSARTAN;

ANTIHYPERTENSIVE ACTIVITY; BLOOD PRESSURE REGULATION; DRUG EFFECT; DRUG EFFICACY; HYPERTENSION; PRESSOR RESPONSE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; SHORT SURVEY;

EID: 0036562928     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200205000-00017     Document Type: Short Survey

References (15)

1. Does aspirin interfere with the therapeutic efficacy of angiotensin-converting ensyme inhibitors or congestive cardiac failure?
2. Effects of low-dose aspirin on clinic and ambulatory blood pressure in treated hypertensive patients. Collaborative Group of the Primary Prevention Project (PPP)-Hypertension study
3. Differential effects of sulindac and indemethacin on blood pressure in treated essential hypertensives
4. The effects of indomethacin and sulindac upon the blood pressure of individuals with untreated labile or mild hypertension
5. NSAIDs and blood pressure. Clinical importance for older patients
6. Effect of indomethacin on the antihypertensive efficacy of valsartan and lisinopril: A multicenter study
7. Effect of indomethacin on blood pressure lowering by captopril and losartan in hypertensive patients
8. Effect of indomethacin on the renal responses to angiotensin receptor blockade in healthy subjects
9. Effect of indomethacin on blood pressure in elderly people with essential hypertension well controlled on amlodipine or enalapril
10. Influence of non steroidal anti-inflammatory drugs on renal function and 24 hour ambulatory blood pressure reducing effects of enalapril and nifedipine gastrointestinal therapeutic system in hypertensive patients
11. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
12. Interaction between nonsteroidal anti-inflammatory drug intake and calcium- channel blocker-based antihypertensive treatment in the Syst-Eur trial
13. Risk of cardiovascular events associated with selective COX-2 inhibitors
14. Effects of nonsteroidal anti-inflammatory drugs on renal function: Focus on cyclooxygenase-2-selective inhibition
15. Renal and related cardiovascular effects of conventional and COX-2-specific NSAIDs and non-NSAID analgesics